Viewing Study NCT03278405


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-02-05 @ 11:54 PM
Study NCT ID: NCT03278405
Status: COMPLETED
Last Update Posted: 2020-03-18
First Post: 2017-08-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Avelumab in G3 NEC
Sponsor: Sunnybrook Health Sciences Centre
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Carcinoma View
Keywords: